Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online: 481

Year : 2006  |  Volume : 3  |  Issue : 1  |  Page : 6-13

Profile of Graves' disease in a tertiary hospital in Northern India and treatment with medical therapy

1 Endocrinologist, All India Institute of Medical Sciences, New Delhi-110 029, India
2 Assistant Professor, All India Institute of Medical Sciences, New Delhi-110 029, India
3 Professor, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi-110 029, India
4 Biostatistician, All India Institute of Medical Sciences, New Delhi-110 029, India

Correspondence Address:
A C Ammini
Biostatistician, All India Institute of Medical Sciences, New Delhi-110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

The present study is a two year retrospective analysis of Graves' disease patients who presented to the AIIMS Endocrinology outpatient department during January 2002 to December 2003. Of 214 patients with Graves ' disease, 130 were females and 84 males. The average age at the onset of disease was 34.8 ± 11.9 years (11-70 years) and the average duration of the disease was 8.4 ± 6.5 months. Weight loss, palpitations, diaphoresis and tremulousness were the most common presenting complaints. A goitre of varying grades (Grade 1=32.6%, Grade 2=58.3%) was present in 85.2% of the patients. An infiltrative ophthalmopathy was present in 44 patients and pretibial myxedema was present in one patient. Of 214 patients, 15 patients were advised surgery, 42 patients were advised radiotherapy and rest were put on medical therapy. Patients with a minimum follow-up of four months on Carbimazole were included for analysis. The patients followed up for an average period of 8.6 ± 4.2 months at mean follow-up intervals of 2.7 ± 1.7 months. An initial euthyroid state could be achieved (82.9%) and maintained in a majority (75.6%) of patients. The average dose and duration to achieve euthyroidism was 30.05 ±0.8 mg and3.2 ±2.4 months respectively. Amongst 34patients who achieved euthyroidism, 19 patients were initiated on a 30 mg dose, 6 on a 20 mg dose and 5 patients were initiated on a 45 mg dose. The average duration to become euthyroid was similar (2.2 ±1.1, 3.5 ± 2.6 and 2.4 ±1.1 months respectively) with the three treatment doses used (p value=0.65). Conclusion- We conclude that medical therapy is an effective means to achieve and maintain euthyroidism. Low dose of Carbimazole is as effective as the higher dose in achieving euthyroidism.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded206    
    Comments [Add]    

Recommend this journal